Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.
about
Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.Nanomedicine for the treatment of Alzheimer's disease.Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid Conjugate for Alzheimer's disease Intervention.In silico analytico-mathematical interpretation of biopolymeric assemblies: Quantification of energy surfaces and molecular attributes via atomistic simulations
P2860
Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Surface-engineered nanoliposom ...... egates of Alzheimer's disease.
@en
Surface-engineered nanoliposom ...... egates of Alzheimer's disease.
@nl
type
label
Surface-engineered nanoliposom ...... egates of Alzheimer's disease.
@en
Surface-engineered nanoliposom ...... egates of Alzheimer's disease.
@nl
prefLabel
Surface-engineered nanoliposom ...... egates of Alzheimer's disease.
@en
Surface-engineered nanoliposom ...... egates of Alzheimer's disease.
@nl
P2093
P2860
P50
P1476
Surface-engineered nanoliposom ...... egates of Alzheimer's disease.
@en
P2093
Dinesh Naidoo
Maluta S Mufamadi
Sunny E Iyuke
Valence M K Ndesendo
P2860
P304
P356
10.1007/S11095-012-0770-0
P577
2012-05-15T00:00:00Z